GlassScriptPhysician profile
William L Harris
NPI 1427238831
$14,651.89
in general payments reported to CMS, 2019-2025
52 companies · $3,153 in 2025
The $3,153 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,228 · 2020: $491 · 2021: $1,535 · 2022: $1,567 · 2023: $2,232 · 2024: $3,446 · 2025: $3,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,830.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,020.44 | 2021-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $943.11 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $911.48 | 2022-2025 | In.Pact Av, Symplicity G3, Cobalt Dr Mri Surescan |
| Abiomed | $880.59 | 2019-2025 | Impella |
| Asahi Intecc USA, INC. | $590.13 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $572.02 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $523.85 | 2019-2025 | Farxiga, Wainua |
| Amgen INC. | $521.65 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $521.64 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $472.25 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $397.67 | 2021-2025 | Jardiance |
| Philips North America LLC | $376.50 | 2019-2025 | Coronary Other, (6585) Omniwire, (6571) Eagle Eye |
| Abbott Laboratories | $360.68 | 2019-2025 | Coroflow, Cardiomems, Diamondback Coronary |
| Cardiovascular Systems INC. | $347.55 | 2019-2022 | |
| Endologix LLC | $285.66 | 2024 | Torus Stent Graft System, Endocross Device |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $282.09 | 2020-2022 | |
| Esperion Therapeutics, INC. | $241.08 | 2020-2025 | Nexletol |
| Irhythm Technologies, INC. | $235.97 | 2020-2024 | Zio Monitor, Zio Xt Patch |
| Inari Medical, INC. | $233.85 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $216.21 | 2022-2024 | Xarelto |
| Medtronic Vascular, INC. | $214.89 | 2019 | |
| Shockwave Medical, INC | $213.55 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $188.07 | 2025 | Amvuttra, Onpattro |
| Pfizer INC. | $182.12 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $180.96 | 2021-2025 | Verquvo |
| Scpharmaceuticals INC. | $180.61 | 2024 | |
| Cleerly, INC. | $175.00 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Opsens INC. | $117.33 | 2019 | |
| Cardiva Medical, INC. | $113.44 | 2019-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Bayer Healthcare Pharmaceuticals INC. | $112.08 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $108.69 | 2019-2023 | |
| Angiodynamics, INC. | $108.21 | 2019 | |
| Cook Medical LLC | $103.64 | 2019 | |
| Vital Connect, INC | $100.15 | 2023-2024 | Vitalpatch Rtm |
| Atricure, INC. | $91.21 | 2022-2024 | |
| Terumo Medical Corporation | $55.25 | 2019-2025 | Metacross Otw, Angio-Seal, Heartrail |
| Teleflex LLC | $54.97 | 2024-2025 | Turnpike, Vascband, Trapliner |
| Novo Nordisk INC | $52.07 | 2021 | |
| Daiichi Sankyo INC. | $45.02 | 2022-2023 | Injectafer |
| Amarin Pharma, INC. | $38.38 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $37.80 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $32.65 | 2024 | Opsumit, Uptravi |
| Baxter Healthcare | $30.51 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Bridgebio Pharma, INC. | $29.61 | 2025 | Attruby |
| Heartflow, INC. | $23.33 | 2025 | |
| Kestra Medical Technology Services, INC. | $22.86 | 2024 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $22.78 | 2023 | Inpefa |
| Cardinal Health 200 LLC | $22.42 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $19.96 | 2023 | Arcalyst |
| Teva Pharmaceuticals USA, INC. | $14.60 | 2024 | Austedo Xr |
| Cvrx, INC. | $14.50 | 2022 | |
| B. Braun Interventional Systems INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.